Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Enforcement Roundup: Daniel Chapter One, Peanut Corp. Of America

This article was originally published in The Tan Sheet

Executive Summary

Final chapter for Daniel Chapter One owner; prison sentence for head of salmonella-tainted peanut firm.

You may also be interested in...



Warning Letters Mount As FDA Completes Initial Inspections Of Under-The-Radar Facilities

Later this year, FDA expects to complete initial inspections of every facility that manufactures drugs for the US market. As the agency visits under-the-radar facilities recently targeted as part of an effort to leave no site uninspected, it is finding that they are more likely to have serious drug GMP issues.

Nutritional Bars Caught In Listeria-Contaminated Nut Ingredient Recalls

Bulletproof 360's recall announcement says HVF Inc. supplied potentially contaminated cashew butter used in its products, and GoMacro received almond ingredients for its products from HVF.

Tracking Federal Agencies’ Enforcement In Supplement Space

““The Tan Sheet” provides links to previous articles on many of the enforcements DoJ announced from its year-long sweep.

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS107918

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel